Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases
Ulrike Billmeier(Friedrich-Alexander-Universität Erlangen-Nürnberg), Raja Atreya(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 211
Related Papers
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune‐mediated inflammatory diseases: A European retrospective observational study
|United European Gastroenterology Journal|2021|71
Metabolic stress sensing by epithelial RXRα links westernization of diet with Crohn’s disease
|Cell Metabolism|2025|2